| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |